Pharma News

Keep updating your pharma knowledge
14 May 2016

Piramal Enterprises’ Consumer Products Division to acquire four consumer products brands from Pfizer

Piramal Enterprises’ Consumer Products Division has entered into an agreement to acquire four brands from Pfizer Limited for a consideration of Rs 110 crore. The acquisition includes brands namely Ferradol, Neko, Sloan’s and Waterbury’s compound. Additionally the agreement also includes the trademark rights for Ferradol and Waterbury’s compound in Bangladesh and Sri Lanka. These brands hold a rich legacy and have a high consumer pull and are available in India for the past 30+ years
These products currently operate in a market which is currently estimated at Rs.7,000 crore. Completion of the deal is subject to certain conditions including regulatory approvals.
These products from Pfizer will fit to portfolio of Piramal Consumer division. Piramal consumer division is looking to combine existing core brands and strategically acquiring accretive brands to create a healthy powerful portfolio of OTC brands in India.
Few Facts:
  • Piramal Enterprises’ Consumer Products Division is having leading brands like Saridon, Ipill, Lacto Calamine, Tetmosol and Caladryl.
  • The division is having 6 of brands in the top 100 OTC brands of India.
  • The Consumer Products Division of the company currently ranks 7th in India; but we aim to be a Top 3 player in the OTC market by 2020.
  • Company have done two acquisitions in the Consumer Products business. The first one was the Littles baby care range of brands and second was the gastro-intestinal portfolio of brands from MSD.

Leave a Reply

The reCAPTCHA verification period has expired. Please reload the page.

Upskill Your Pharma Knowledge

Explore Next Gen Learning

Case Studies & Caselets | Simulation Based Learning | E-Lectures | Online Self Competency Assessments

Thank You for Subscription!